Management and outcome of male metastatic breast cancer in the national multicenter observational research program Epidemiological Strategy and Medical Economics (ESME).

Junien SirieixJulien FraisseSimone Mathoulin-PelissierMarianne LeheurteurLaurence VanlemmensChristelle JouannaudVéronique DiérasChristelle LévyMony UngMarie-Ange Mouret-ReynierThierry PetitBruno CoudertEtienne G C BrainBarbara PistilliJean-Marc FerreroAnthony GoncalvesLionel UwerAnne PatsourisOlivier TredanCoralie CourtinardSophie GourgouJean-Sébastien Frenel

Published in: Therapeutic advances in medical oncology (2020)

MBC management in men and women leads to similar outcomes, especially in HR+/HER2- patients for whom ET should also be a cornerstone. Unsolved questions remain and successfully recruiting trials for men are still lacking.

Keyphrases

metastatic breast cancer
end stage renal disease
quality improvement
chronic kidney disease
ejection fraction
newly diagnosed
healthcare
cross sectional
peritoneal dialysis
prognostic factors
adipose tissue
insulin resistance
patient reported